A cohort study of 245 patients revealed that 45% of the tumors expressed Her2/neu protein and expression correlated with higher grade, tumor recurrence, and decreased survival, especially when co-expressed with ErbB1 or ErbB3 [8]. Here, ERBB2 is linked to neoplasm.